Led by IVCC, the New Nets Project is piloting new tools to strengthen the insecticide-treated net (ITN) market. Project partner Molly Robertson of PATH has written a blog following the publication of interim analyses that illustrates the potential effectiveness of new ITN types. Read more here.

IVCC’s Annual report for 2021 has been published. The report showcases IVCC’s work to facilitate innovative approaches to preventing vector-borne diseases and tackle the growing threat of insecticide resistance. With activities across the globe and spanning research and development and market access, we are accelerating the process from innovation to impact. The report is a reminder of the importance of collaborative working and the progress laid out in it is testament, too, to the commitment of our partners from industry, academia, the public sector and advocacy. We are grateful for the support of all of our funders, who make life-saving vector control possible.

The IVCC Annual Report 2022-2023 has been published.

The report showcases IVCC’s work to facilitate innovative approaches to preventing vector-borne diseases and tackle the growing threat of insecticide resistance. With activities across the globe and spanning research and development and market access, we are accelerating the process from innovation to impact.

The report is a reminder of the importance of collaborative working and the progress laid out in it is testament, too, to the commitment of our partners from industry, academia, the public sector, and advocacy. We are grateful for the support of all our funders, who make life-saving vector control possible.

Earlier in 2023 IVCC embarked upon a strategic review to assess and realign priorities to ensure that we are focusing on the unmet needs that will have the most significant impact against vector-borne disease. The annual report outlines IVCC’s strategic priorities going forward.

Another highlight is a section on climate change and the dramatic impact it is having on vector-borne disease transmission, demanding new policies, tools and approaches.

“At this pivotal time for global health, I call upon the wider global community to ensure that, as IVCC and its partnerships continue with their missions, appropriate political will and funding, facilitates and strengthens our collective efforts to eradicate malaria and the neglected tropical diseases that afflict the most vulnerable members of society.”

Sherwin Charles, Chair, Board of Trustees, IVCC.

For more information or to request a physical copy please provide your full name and postal address to Laura Roberts on laura.roberts@ivcc.com.

Download the Tech Updates highlighting vector biology and control news, publications and resources.

Given the breadth of vector control-related literature, we are unable to include all relevant work. These updates are intended to focus primarily on Anopheles biology and a subset of control topics with global relevance.

Any views expressed in the updates do not necessarily reflect the views or opinions of IVCC. In many cases, we directly quote sections of published work. Mention of trade names or commercial products is solely for the purpose of providing specific information and does not imply recommendation or endorsement by IVCC or its funders.

The Vector Expedited Review Voucher (VERV), modelled on the already established US Priority Review Voucher (PRV) for drug development, is a proposed no cost new incentive to encourage R&D focussed agriculture companies to innovate in public health where there are significant economic barriers to product innovation. The VERV would encourage companies to invest in novel insecticide development for public health, such as malaria, by rewarding the registrant of a new public health insecticide with a voucher to receive an expedited review of a second, more profitable product outside public health. Getting to market faster is valuable and gives an innovator registrant an opportunity to generate a financial return to mitigate the development cost losses on a public health use insecticide.